HUP0303584A2 - Egy hidroximsav-halogenid-származék alkalmazása neurodegeneratív betegségek kezelésére - Google Patents
Egy hidroximsav-halogenid-származék alkalmazása neurodegeneratív betegségek kezeléséreInfo
- Publication number
- HUP0303584A2 HUP0303584A2 HU0303584A HUP0303584A HUP0303584A2 HU P0303584 A2 HUP0303584 A2 HU P0303584A2 HU 0303584 A HU0303584 A HU 0303584A HU P0303584 A HUP0303584 A HU P0303584A HU P0303584 A2 HUP0303584 A2 HU P0303584A2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- neurodegenerative diseases
- acid halide
- hydroximic acid
- halide derivative
- Prior art date
Links
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000004820 halides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- SGEIEGAXKLMUIZ-PEZBUJJGSA-N (3z)-n-(2-hydroxy-3-piperidin-1-ylpropoxy)-1-oxidopyridin-1-ium-3-carboximidoyl chloride Chemical compound C1CCCCN1CC(O)CO\N=C(/Cl)C1=CC=C[N+]([O-])=C1 SGEIEGAXKLMUIZ-PEZBUJJGSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
(57) A találmány tárgya egy, az N-[2-hidroxi-3-(1-piperidinil)-propoxi]- piridin-1-oxid-3-karboximidoil-klorid, annak optikailagaktív enantiomerjei, az enantiomerek keverékei, valamint a racémvegyület és az optikailag aktív vegyületek gyógyászati szempontbólelfogadható sói által alkotott csoporthoz tartozó kémiai vegyületalkalmazása neurodegeneratív betegségek kezelésére vagy megelőzésérehasználható gyógyászati kompozíció előállításában.
Priority Applications (30)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0303584A HUP0303584A3 (en) | 2003-10-30 | 2003-10-30 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
EP04791657A EP1696922B1 (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
EP08157425A EP2020233A3 (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
KR1020067010489A KR20060103323A (ko) | 2003-10-30 | 2004-10-25 | 신경변성 질환의 치료에서 히드록심산 할라이드 유도체의용도 |
PCT/HU2004/000098 WO2005041965A1 (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
ZA200604376A ZA200604376B (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
CNA2004800396198A CN1901913A (zh) | 2003-10-30 | 2004-10-25 | 羟肟酸卤化物衍生物在治疗神经变性疾病中的用途 |
SI200430887T SI1696922T1 (sl) | 2003-10-30 | 2004-10-25 | Uporaba halogenidnega derivata hidroksimske kisline pri zdravljenju nevrodegenerativnih bolezni |
CA2544332A CA2544332C (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
PL04791657T PL1696922T3 (pl) | 2003-10-30 | 2004-10-25 | Zastosowanie pochodnych halogenków kwasu hydroksymowego w leczeniu chorób neurodegeneracyjnych |
NZ547216A NZ547216A (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
PT04791657T PT1696922E (pt) | 2003-10-30 | 2004-10-25 | Utilização de um derivado de halogeneto de ácido hidroxímico no tratamento de doenças neurodegenerativas |
EA200600866A EA011301B1 (ru) | 2003-10-30 | 2004-10-25 | Применение галоидного производного гидроксимовой кислоты для лечения нейродегенеративных заболеваний |
ES04791657T ES2314458T3 (es) | 2003-10-30 | 2004-10-25 | Uso de un derivado de haluro de acido hidroximico para el tratamiento de enfermedades neurodegenerativas. |
DE602004016770T DE602004016770D1 (de) | 2003-10-30 | 2004-10-25 | Verwendung eines hydroximinsäure-halogenid-derivats bei der behandlung von neurodegenerativen erkrankungen |
DK04791657T DK1696922T3 (da) | 2003-10-30 | 2004-10-25 | Anvendelse af et hydroximinsyre-halogenid-derivat til behandling af neurodegenerative sygdomme |
JP2006537449A JP5077997B2 (ja) | 2003-10-30 | 2004-10-25 | 神経変性疾患の治療におけるヒドロキシム酸クロライドの使用 |
CZ20060347A CZ2006347A3 (cs) | 2003-10-30 | 2004-10-25 | Pouzití derivátu halogenidu kyseliny hydroximové pro lécbu neurodegenerativních chorob |
US10/582,124 US20080039497A1 (en) | 2003-10-30 | 2004-10-25 | Use Of A Hydroximic Acid Halide Derivative In The Treatment Of Neurodegenerative Diseases |
AU2004285343A AU2004285343B2 (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
UAA200605899A UA86782C2 (ru) | 2003-10-30 | 2004-10-25 | Применение галоидного производного гидроксамовой кислоты в лечении нейродегенеративных заболеваний центральной нервной системы |
BRPI0415625-0A BRPI0415625A (pt) | 2003-10-30 | 2004-10-25 | uso de um derivado de halogeneto de ácido hidroxìmico no tratamento de hidroxìmico no tratamento de doenças neurogenerativas |
AT04791657T ATE409038T1 (de) | 2003-10-30 | 2004-10-25 | Verwendung eines hydroximinsäure-halogenid- derivats bei der behandlung von neurodegenerativen erkrankungen |
IL175334A IL175334A (en) | 2003-10-30 | 2006-04-30 | Use of a hydroximic acid halide derivative in the preparation of a medicament for the treatment of neurodegenerative diseases and composition comprising same |
NO20062401A NO20062401L (no) | 2003-10-30 | 2006-05-26 | Anvendelse av et hydroksimsyrehalidderivat i behandling av neurodegenerative sykdommer |
HK07102495.9A HK1097438A1 (en) | 2003-10-30 | 2007-03-06 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
CY20081101426T CY1110450T1 (el) | 2003-10-30 | 2008-12-10 | Χρησιμοποιηση ενος παραγωγου αλογονιδιου υδροξιμικου οξεος στη θεραπευτικη αγωγη νευροεκφυλιστικων νοσων |
HR20080660T HRP20080660T3 (en) | 2003-10-30 | 2008-12-19 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
US13/229,862 US8962604B2 (en) | 2003-10-30 | 2011-09-12 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
US14/594,817 US20150126551A1 (en) | 2003-10-30 | 2015-01-12 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0303584A HUP0303584A3 (en) | 2003-10-30 | 2003-10-30 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0303584D0 HU0303584D0 (en) | 2003-12-29 |
HUP0303584A2 true HUP0303584A2 (hu) | 2005-12-28 |
HUP0303584A3 HUP0303584A3 (en) | 2009-12-28 |
Family
ID=89981738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0303584A HUP0303584A3 (en) | 2003-10-30 | 2003-10-30 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
Country Status (27)
Country | Link |
---|---|
US (3) | US20080039497A1 (hu) |
EP (2) | EP1696922B1 (hu) |
JP (1) | JP5077997B2 (hu) |
KR (1) | KR20060103323A (hu) |
CN (1) | CN1901913A (hu) |
AT (1) | ATE409038T1 (hu) |
AU (1) | AU2004285343B2 (hu) |
BR (1) | BRPI0415625A (hu) |
CA (1) | CA2544332C (hu) |
CY (1) | CY1110450T1 (hu) |
CZ (1) | CZ2006347A3 (hu) |
DE (1) | DE602004016770D1 (hu) |
DK (1) | DK1696922T3 (hu) |
EA (1) | EA011301B1 (hu) |
ES (1) | ES2314458T3 (hu) |
HK (1) | HK1097438A1 (hu) |
HR (1) | HRP20080660T3 (hu) |
HU (1) | HUP0303584A3 (hu) |
IL (1) | IL175334A (hu) |
NO (1) | NO20062401L (hu) |
NZ (1) | NZ547216A (hu) |
PL (1) | PL1696922T3 (hu) |
PT (1) | PT1696922E (hu) |
SI (1) | SI1696922T1 (hu) |
UA (1) | UA86782C2 (hu) |
WO (1) | WO2005041965A1 (hu) |
ZA (1) | ZA200604376B (hu) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1615296A (zh) | 2002-01-11 | 2005-05-11 | 拜奥列克斯研究发展公司 | 甲脒衍生物及其在治疗血管疾病中的用途 |
US20080227813A1 (en) * | 2006-09-26 | 2008-09-18 | Jack Raymond Barber | Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration |
PL2659904T3 (pl) | 2008-06-26 | 2016-01-29 | Orphazyme Aps | Zastosowanie Hsp70 jako regulatora aktywności enzymatycznej |
EA201100805A1 (ru) | 2008-11-18 | 2011-10-31 | Сантен Фармасьютикал Ко., Лтд. | Терапевтический агент при хориоретинальном дегенеративном заболевании, содержащий в качестве активного ингредиента производное пиридин-3-карбальдегид-o-(пиперидин-1-илпропил)оксима |
PL2646044T3 (pl) | 2010-11-30 | 2020-03-31 | Orphazyme A/S | Sposoby zwiększenia aktywności wewnątrzkomórkowej Hsp70 |
HUP1100534A2 (en) * | 2011-09-26 | 2013-04-29 | Balazs Dr Hazay | Pharmaceutical composition for the treatment of muscle atrophy |
CN103804309B (zh) * | 2012-11-09 | 2019-08-02 | 广州喜鹊医药有限公司 | 一种氯肟类化合物及其制备方法和在制药中的应用 |
JP6678676B2 (ja) * | 2014-09-15 | 2020-04-08 | オーファザイム エー/エス | アリモクロモル製剤 |
US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
EP3448382B1 (en) | 2016-04-29 | 2020-10-14 | Orphazyme A/S | Arimoclomol for treating glucocerebrosidase associated disorders |
US20200085812A1 (en) | 2017-05-24 | 2020-03-19 | Orphazyme A/S | Heat shock protein inducers and frontotemporal disorders |
HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
US20230416224A1 (en) | 2020-11-19 | 2023-12-28 | Zevra Denmark A/S | Processes for preparing arimoclomol citrate and intermediates thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU177578B (en) | 1976-08-27 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives |
DE2651083A1 (de) * | 1976-11-09 | 1978-05-18 | Hoechst Ag | Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung |
HU207988B (en) | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
HUT54347A (en) * | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
US5334600A (en) * | 1991-07-30 | 1994-08-02 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
WO1995030649A1 (en) | 1994-05-06 | 1995-11-16 | Biorex Kutató És Fejleszto^' Rt. | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
HU9502843D0 (en) | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
UA64716C2 (en) | 1996-08-09 | 2004-03-15 | Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells | |
HU220971B1 (hu) | 1997-04-03 | 2002-07-29 | BIOREX Kutató és Fejlesztő Rt. | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
UA65635C2 (uk) * | 1998-09-03 | 2004-04-15 | Н-Гене Кутато Кфт. | НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ |
HUP9900475D0 (en) * | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
HUP0001583A2 (hu) | 2000-04-18 | 2002-11-28 | BIOREX Kutató és Fejlesztő Rt. | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké |
HU0103939D0 (en) | 2001-09-27 | 2001-11-28 | Biorex Kutato Fejlesztoe Kft | Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride |
ITMI20012573A1 (it) | 2001-12-06 | 2003-06-06 | D B P Dev Biotechonologica L P | Gli acilsalicilati:una nuova classe di induttori di risposta heat shock |
-
2003
- 2003-10-30 HU HU0303584A patent/HUP0303584A3/hu unknown
-
2004
- 2004-10-25 JP JP2006537449A patent/JP5077997B2/ja not_active Expired - Fee Related
- 2004-10-25 AU AU2004285343A patent/AU2004285343B2/en not_active Ceased
- 2004-10-25 AT AT04791657T patent/ATE409038T1/de active
- 2004-10-25 CA CA2544332A patent/CA2544332C/en not_active Expired - Fee Related
- 2004-10-25 DE DE602004016770T patent/DE602004016770D1/de active Active
- 2004-10-25 EA EA200600866A patent/EA011301B1/ru not_active IP Right Cessation
- 2004-10-25 CN CNA2004800396198A patent/CN1901913A/zh active Pending
- 2004-10-25 BR BRPI0415625-0A patent/BRPI0415625A/pt not_active Application Discontinuation
- 2004-10-25 SI SI200430887T patent/SI1696922T1/sl unknown
- 2004-10-25 ES ES04791657T patent/ES2314458T3/es active Active
- 2004-10-25 NZ NZ547216A patent/NZ547216A/en unknown
- 2004-10-25 ZA ZA200604376A patent/ZA200604376B/xx unknown
- 2004-10-25 UA UAA200605899A patent/UA86782C2/ru unknown
- 2004-10-25 EP EP04791657A patent/EP1696922B1/en active Active
- 2004-10-25 EP EP08157425A patent/EP2020233A3/en not_active Withdrawn
- 2004-10-25 DK DK04791657T patent/DK1696922T3/da active
- 2004-10-25 CZ CZ20060347A patent/CZ2006347A3/cs unknown
- 2004-10-25 PL PL04791657T patent/PL1696922T3/pl unknown
- 2004-10-25 KR KR1020067010489A patent/KR20060103323A/ko not_active Application Discontinuation
- 2004-10-25 PT PT04791657T patent/PT1696922E/pt unknown
- 2004-10-25 US US10/582,124 patent/US20080039497A1/en not_active Abandoned
- 2004-10-25 WO PCT/HU2004/000098 patent/WO2005041965A1/en active IP Right Grant
-
2006
- 2006-04-30 IL IL175334A patent/IL175334A/en not_active IP Right Cessation
- 2006-05-26 NO NO20062401A patent/NO20062401L/no not_active Application Discontinuation
-
2007
- 2007-03-06 HK HK07102495.9A patent/HK1097438A1/xx not_active IP Right Cessation
-
2008
- 2008-12-10 CY CY20081101426T patent/CY1110450T1/el unknown
- 2008-12-19 HR HR20080660T patent/HRP20080660T3/xx unknown
-
2011
- 2011-09-12 US US13/229,862 patent/US8962604B2/en not_active Expired - Fee Related
-
2015
- 2015-01-12 US US14/594,817 patent/US20150126551A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175334A0 (en) | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases | |
HUP0400636A2 (hu) | Azetidinszármazékokat tartalmazó gyógyszerkészítmények, új azetidinszármazékok és előállításuk | |
SE0104340D0 (sv) | New compounds | |
HUP0303891A2 (hu) | Gyógyhatású piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
NO20051263L (no) | Ny anvendelse av benzotiazolderivater | |
SE0104334D0 (sv) | Therapeutic agents | |
NO20052914L (no) | Terapeutiske forbindelser | |
YU65804A (sh) | Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze | |
SE0104341D0 (sv) | New use | |
NO20045137L (no) | Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens | |
DE502004005033D1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
UA85359C2 (ru) | Таблетка, содержащая гранулированный материал с kmd-3213 | |
NI200400073A (es) | Compuestos de fenilsulfonamida sustituida inhibidores de la produccion de beta-amiloide | |
EA200001061A1 (ru) | Фармацевтическая композиция | |
HUP0402577A2 (hu) | Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra | |
SE0102440D0 (sv) | New compound | |
HRP20050831A2 (en) | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents | |
HUP0300863A2 (hu) | N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény | |
SE9901572D0 (sv) | New compounds | |
SE0201837D0 (sv) | Chemical compounds | |
SE9900190D0 (sv) | New compounds | |
HUP0401798A2 (hu) | Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására | |
SE0203778D0 (sv) | A new oral immediated release dosage form | |
NO20043397L (no) | Prucaloprid-N-oksid | |
HUP0202114A2 (hu) | Benzoesavval szubsztituált benzopiránok alkalmazása atherosclerosis kezelésére alkalmas gyógyszerkészítményekben és a készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: CYTRX CORPORATION, US Free format text: FORMER OWNER(S): BIOREX KUTATO ES FEJLESZTOE RT., HU |
|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |